General Information


DRAVP ID  DRAVPe02084

Peptide Name   Mastoparan-MO

Sequence  FLPIIINLKALAALAKKIL

Sequence Length  19

UniProt ID  P01514 

Taxon ID  7452 

Source  Venom, Vespula lewisii

Validation   Experimentally Validated



Origin Information


Gene Name/ID  Not Available

GenBank  Not Available

Amino Acid position  Not Available

Domain Accession ID  Not Available

Nucleotide sequence ID  Not Available

Molecular Type  Not Available

Chromosomal Position  Not Available



Activity Information


Target Organism  HSV-1

Assay  Plaque Assay

Activity 

  • [Ref:38932240]Human alphaherpesvirus 1 (HSV-1): Inhibited entry (EC50 = 6.68 µM).

Hemolytic Activity  No hemolysis information or data found in the reference(s) presented in this entry

Cytotoxicity 

  • [Ref:38932240]:CC50=>200 µg.mL−1

Binding Target  Membrane

Mechanism  Mastoparan-MO exhibited over 80% HSV-1 inhibition, with up to 99% viral replication inhibition, particularly in the early infection stages.



Structure Information


PDB ID  6DUU) 

Predicted Structure Download  No predicted structure available

Linear/Cyclic  Linear

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Stereochemistry  L



Physicochemical Information


Formula  C102H179N23O21

Absent amino acids  RDCEQGHMSTWYVOU

Common amino acids  L

Mass  2063.68

Pl  10.03

Basic residues  3

Acidic residues  0

Hydrophobic residues  15

Net charge  3

Boman Index  0.8211

Hydrophobicity  1.589

Aliphatic Index  205.79

Half Life 

  •     Mammalian:1.1 hours
  •     Yeast:3 min
  •     E.coli:2 min

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  4



Literature Information


Literature 1

Title   Antiviral Activities of Mastoparan-L-Derived Peptides against Human Alphaherpesvirus 1

Pubmed ID   38932240

Reference   Viruses. 2024 Jun 12;16(6)

Author   Vilas Boas LCP, Buccini DF, Berlanda RLA, Santos BPO, Maximiano MR, Lião LM, Gonçalves S, Santos NC, Franco OL.

DOI    10.3390/v16060948